FDANews
The QMN Weekly Bulletin

API Maker Gets Form 483 for Minimal Materials Testing

Nov. 29, 2013
Avatar Corporation was chided by the FDA for not always testing active pharmaceutical ingredients (API) against USP monographs. FDA investigators found the poor testing record during a July inspection of the company’s University Park, Ill., facility.
Drug GMP Report